BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1029 related articles for article (PubMed ID: 11058129)

  • 1. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.
    Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P
    Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
    Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
    EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human T-cell leukemia virus type I oncoprotein Tax represses Smad-dependent transforming growth factor beta signaling through interaction with CREB-binding protein/p300.
    Mori N; Morishita M; Tsukazaki T; Giam CZ; Kumatori A; Tanaka Y; Yamamoto N
    Blood; 2001 Apr; 97(7):2137-44. PubMed ID: 11264182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta inhibits pulmonary surfactant protein B gene transcription through SMAD3 interactions with NKX2.1 and HNF-3 transcription factors.
    Li C; Zhu NL; Tan RC; Ballard PL; Derynck R; Minoo P
    J Biol Chem; 2002 Oct; 277(41):38399-408. PubMed ID: 12161428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.
    Feng XH; Lin X; Derynck R
    EMBO J; 2000 Oct; 19(19):5178-93. PubMed ID: 11013220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two short segments of Smad3 are important for specific interaction of Smad3 with c-Ski and SnoN.
    Mizuide M; Hara T; Furuya T; Takeda M; Kusanagi K; Inada Y; Mori M; Imamura T; Miyazawa K; Miyazono K
    J Biol Chem; 2003 Jan; 278(1):531-6. PubMed ID: 12426322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smad3 is acetylated by p300/CBP to regulate its transactivation activity.
    Inoue Y; Itoh Y; Abe K; Okamoto T; Daitoku H; Fukamizu A; Onozaki K; Hayashi H
    Oncogene; 2007 Jan; 26(4):500-8. PubMed ID: 16862174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
    Poncelet AC; de Caestecker MP; Schnaper HW
    Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linking Smads and transcriptional activation.
    Inman GJ
    Biochem J; 2005 Feb; 386(Pt 1):e1-e3. PubMed ID: 15702493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
    Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
    Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3.
    Yuan W; Varga J
    J Biol Chem; 2001 Oct; 276(42):38502-10. PubMed ID: 11502752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between Smad anchor for receptor activation and Smad3 is not essential for TGF-beta/Smad3-mediated signaling.
    Goto D; Nakajima H; Mori Y; Kurasawa K; Kitamura N; Iwamoto I
    Biochem Biophys Res Commun; 2001 Mar; 281(5):1100-5. PubMed ID: 11243848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-beta-stimulated cooperation of smad proteins with the coactivators CBP/p300.
    Janknecht R; Wells NJ; Hunter T
    Genes Dev; 1998 Jul; 12(14):2114-9. PubMed ID: 9679056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional conservation of Schistosoma mansoni Smads in TGF-beta signaling.
    Beall MJ; McGonigle S; Pearce EJ
    Mol Biochem Parasitol; 2000 Nov; 111(1):131-42. PubMed ID: 11087923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes.
    Liu F; Pouponnot C; Massagué J
    Genes Dev; 1997 Dec; 11(23):3157-67. PubMed ID: 9389648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic triterpenoids enhance transforming growth factor beta/Smad signaling.
    Suh N; Roberts AB; Birkey Reffey S; Miyazono K; Itoh S; ten Dijke P; Heiss EH; Place AE; Risingsong R; Williams CR; Honda T; Gribble GW; Sporn MB
    Cancer Res; 2003 Mar; 63(6):1371-6. PubMed ID: 12649201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of p300, a transcriptional coactivator, in signalling of TGF-beta.
    Nishihara A; Hanai JI; Okamoto N; Yanagisawa J; Kato S; Miyazono K; Kawabata M
    Genes Cells; 1998 Sep; 3(9):613-23. PubMed ID: 9813111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
    Fanayan S; Firth SM; Baxter RC
    J Biol Chem; 2002 Mar; 277(9):7255-61. PubMed ID: 11751851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-beta-induced transcriptional activation.
    Feng XH; Zhang Y; Wu RY; Derynck R
    Genes Dev; 1998 Jul; 12(14):2153-63. PubMed ID: 9679060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of transforming growth factor-beta and bone morphogenetic protein signalling by transcriptional coactivator GCN5.
    Kahata K; Hayashi M; Asaka M; Hellman U; Kitagawa H; Yanagisawa J; Kato S; Imamura T; Miyazono K
    Genes Cells; 2004 Feb; 9(2):143-51. PubMed ID: 15009097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.